Navigation Links
A prognosis for GE and Abbott Diagnostics

What is more important: diagnostics, therapeutics, or prognosis? While all are important, we will in this column see how past history has addressed this question and also how recent events, such as GE's acquisition of Abbott's diagnostics units, shed light on this fundamental issue.

It is al......

Full article >>> t centers.

While his emphasis on treatment facilities was simply an oversight, a radiologist friend of mine couldn't help but cheekily point out whether it meant that diagnostic centers were to be left as open targets. While we were not often in a joking mood during those days, it did point out how deeply ingrained our focus on treatment has become.

While diagnosis plays second f......

Full article >>> such as its pharmaceuticals and devices - are marketed mostly through physicians and direct-to-consumer channels.

GE has a significant marketing advantage and experience when it comes to big-box purchases. Moreover, the GE commercial finance arm also facilitates the ability to purchase these big boxes through leasing or other arrangements. The same marketing strength can also be applied t......

Full article >>> t means that radiologic diagnoses can be done at the bedside with a portable scanner, in the CT/MRI suite or in the ER, as opposed to getting your results later that evening. If you can do that with a huge, multimillion-dollar MRI machine, why can't you do that with a simple blood test?

Indeed, that is the premise behind Abbott's point-of-care system. This is how the cultural paradigm tha......

Full article >>> ts.jsp?release_id=12212">press release does not usually count as high-end literary criticism, reading more deeply reveals some important messages.

In this regard, Abbott may be considering its in-vitro and point-of-care businesses as commodities compared to its molecular business. Without the infusion of GE's hospital-based marketing focus, GE's advanced radiologic technology and GE's......

Full article >>> live, and how well they will live. To answer the question posed at the beginning of this column, most people will agree that in this context, prognosis ranks first.

Abbott is betting on the supremacy of prognosis. While the GE acquisition makes excellent business sense for GE, the future lies with those companies that can accurately, relevantly, and usefully bring prognostic information ......

Full article >>> . He can be e-mailed at ogan@midwestbusiness.com.

This article previously appeared in MidwestBusiness.com, and was reprinted with its permission.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of ......

Full article >>>
'"/>

Source:wistechnology.com By Ogan Gurel 02/05/07


Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. Wisconsin court halts Abbotts sale of genotyping products
3. Wisconsin court affirms damages in Innogenetics, Abbott patent case
4. Abbott Labs campus in Kenosha could send ripples through local biotech
5. Abbott Executive Jim Tyree Takes IBIO Helm
6. Promega Announces Agreement with Abbott
7. Roche Diagnostics Corporation
8. Roche Diagnostics Corporation
9. BioDiagnostics is first seed-testing lab to gain new accreditation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):